Cantonal Hosptal, Baselland Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02386735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Head of Medical University Clinic, Cantonal hospital Baselland | Health Department of the Canton of Basel-Stadt | Prof. Dr. Jörg Leuppi

Active Ingredients

Drugs in Phase 2 Trials (1)

aviptadil (1 trial)

Drugs in Other Trials (2)

prednisone (meticorten) (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3